Kim TH, Jung JW, Ha BG, Hong JM, Park EK, Kim HJ, Kim SY (2011) The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss
Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity
Secondary Outcomes: Changes from baseline to week 12 in body weight, BMI, fasting blood glucose, fasting insulin (FI), glycated hemoglobin (HbA1c), blood lipids, uric acid, liver function, and testosterone in study participants
Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration